Therapeutic drug monitoring of tacrine: Simple and fast high-performance liquid chromatography assay method for its determination in human plasma

Therapeutic Drug Monitoring

Volumn 22, Issue 2, 2000, Pages 225-229

  Chollet, Daniel F ^a,c   Castella, Eliane ^a   Anderegg, Georges ^a   Arnera, Valdo ^a   Hadler, Dietrich ^b  

^a Covance Ctrl Laboratory Services SA ^*  (Switzerland)

^b Takeda Pharma GmbH   (Germany)

^c Bioanalytical Division ^*  (Switzerland)

Author keywords

High performance liquid chromatography drag monitoring; Tacrine

Indexed keywords

TACRINE;

ACCURACY; ALZHEIMER DISEASE; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRECIPITATION; PRIORITY JOURNAL; VALIDATION PROCESS;

CALIBRATION; CHOLINESTERASE INHIBITORS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; HUMANS; TACRINE;

EID: 0034071472     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200004000-00015     Document Type: Article

References (18)

1. Balson R, Gibson PR, Ames D, and Bhathal PS. Tacrine-induced hepatotoxicity, tolerability and management. CNS Drugs 1995;4 (3):168-181.
2. Forsyth DR, Wilcoks GK, Morgan RA, Truman CA, Ford JM, and Roberts CJC. Pharmacokinetics of tacrine hydrochloride in Alzheimer's disease. Clin Pharmacol Ther 1989;46:634-641.
3. Cutler NR, Sedman AJ, Prior P, et al. Steady-state pharmacokinetics of tacrine in patients with Alzheimer's disease. Psychopharmacol Bull 1990;25(2):231-234.
4. Truman CA, Ford JM, and Roberts CJC. Comparison of the chromatographic characteristics of tacrine hydrochloride in human serum with those of in vitro metabolic products from hepatic microsomes. Biochem Pharmacol 1991;42(4):956-959.
5. Ahlin A, Adem A, and Junthe T, Pharmacokinetics of tetrahydroaminoacridine: relations to clinical and biomedical effects in Alzheimer's patients. Int Clin Pharmacol 1994;17:29-36.
6. Eagger SA, and Levi R. Serum levels in tacrine in relation to clinical response in Alzheimer's disease. Int J Geriatr Psychiatry 1992;7:115-119.
7. Watkins PB, Zimmerman HJ, Knapp MJ, et al. Hepatotoxic effects of tracine administration in patients with Alzheimer's disease. JAMA 1994;271(3):992-998.
8. Ford JM, Truman CA, Wilcox G, and Roberts CJC. Serum concentrations of tacrine hydrochloride predict its adverse effects in Alzheimer's disease. Clin Pharmacol Ther 1993;53:691-695.
9. Makela P, M, Truman CA, Ford JM, and Roberts CJC. Characteristics of plasma protein binding of tacrine hydrochloride: a new drug for Alzheimer's disease. Eur J Clin Pharmacol 1994;47:151-155.
10. Park TH, Tachiki KH, Summers WK, et al. Isolation and the fluorometric, high-performance liquid chromatographic determination of tacrine. Anal Biochem 1986;159(2):358-362.
11. Aymard G, Cayre-Castel M, Fernandez C, Lacomblez L, and Diquet B. High-performance liquid chromatography with ultraviolet and fluorimetric detection for the simultaneous determination of tacrine, nimodipine, and their respective metabolites in the plasma of patients with Alzheimer disease. Ther Drug Monit 1998;20: 422-429.
12. Hansen LL, Larsen JT, and Brosen K. Determination of tacrine and its metabolites in human plasma and urine by high-performance liquid chromatography and fluorescence detection. J Chromatogr B Biomed Sci Appl 1998;712:183-191.
13. Hsu RS, Dileo EM, and Chesson SM. High-performance liquid chromatography for the determination of tacrine and its metabolites in plasma. J Chromatogr B Biomed Sci Appl 1990;530:170-176.
14. Ekman L, Lindstrom B, and Roxin P. Determination of tacrine and its 1-hydroxy metabolite in plasma using column liquid chromatography with UV detection. J Chromatogr B Biomed Sci Appl 1989;494:97-402.
15. Forsyth DR, Ford JM, Truman CA, Roberts CJC, and Wilcoks GK. Determination of tacrine hydrochloride in human plasma by chloroform extraction, reversed-phase high-performance liquid chromatography and fluorimetric detection. J Chromatogr B Biomed Sci Appl 1988;433:352-358.
16. Haugley DB, McNaney CA, Collis MS, et al. Simultaneous determination of tacrine and 1-hydroxy-, 2-hydroxy, and 4-hydroxytacrine in human plasma by high-performance liquid chromatography with fluorescence detection. J Pharm Sci 1994;83(11):1582-1585.
17. CPMP Working Party. Directive 75/316/EEC, Tests on Samples of Biological Origin, ref. III/844/87 final. London: The European Agency for the Evaluation of Medicinal Products; (August 1989).
18. Shah VP, Midha KK, Dighe S, et al. Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies. Pharm Res 1992;9(4):588-592.